Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
stock ticker |
| gptkbp:CEO |
gptkb:Kevin_T._Conroy
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:currency |
gptkb:USD
|
| gptkbp:focus |
molecular diagnostics
cancer diagnostics |
| gptkbp:foundedYear |
1995
|
| gptkbp:headquartersLocation |
gptkb:Madison,_Wisconsin,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASDAQ:EXAS
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:ISIN |
US30063P1057
|
| gptkbp:market |
gptkb:NASDAQ_Global_Select_Market
|
| gptkbp:product |
gptkb:Cologuard
gptkb:Oncotype_DX |
| gptkbp:refersTo |
gptkb:Exact_Sciences_Corporation
|
| gptkbp:sector |
healthcare
|
| gptkbp:stockExchange |
gptkb:NASDAQ
gptkb:stock_market_index |
| gptkbp:stockSymbol |
gptkb:EXAS
|
| gptkbp:website |
https://www.exactsciences.com/
|
| gptkbp:bfsParent |
gptkb:Exact_Sciences_Corporation
|
| gptkbp:bfsLayer |
8
|